BioPharmaceutical Company
Our mission
Our Mission is to improve the quality of life and longevity of Patients.

We are developing and implementing Innovative approaches in BioPharmaceuticals to better serve Patients with life-impacting diseases.

Every Patient in the world has the right to Quality Medical treatment. Our goal is to make it affordable.

Who We Are
Rus BioPharm was founded in 2012, as an Integrated full-cycle BioPharmaceutical Company with a focus on:

  • Biological Products and Biosimilars
  • Full portfolio of Asthma and COPD drugs
  • Innovative and technology driven formulations / complex generics
Rus BioPharm is focused on manufacturing of complex generics and biosimilars for severe diseases, including orphan indications.

Rus BioPharm's R&D efforts are directed towards development of well know molecules as well as combination of drugs previously not available in Russia. These combination drugs would vastly enhance the quality of life of the patients and make the drugs more affordable.

Rus BioPharm is also working on development of innovative drugs and biological drugs, with a focus on auto-immune diseases.
Film about of company
Whom We Serve
  • Patients in need of high quality and affordable drugs
  • We develop innovations and localize the production of medicines to increase the availability of medicines for patients
100 Drug Products in development
11 of which are Biosimilars
Facility fully equipped to manufacture 9 Drug Forms
Our Team
Rus BioPharm is a team of highly trained professionals with vast experience and key knowledge of the Pharmaceutical Industry
  • Satya Karm Punia
    President of Rus BioPharm Group
  • Evgenia Shapiro
    Director General
  • Vyacheslav Vodnev
    Director of Plant Operations


More than 30 experienced professionals in R&D

More than 500 employees at the manufacturing facility in Special Economic Zone, Dubna City, Moscow Region.
Lead Therapeutic Areas
Rus BioPharm is actively substituting imported Drug Products through development and local manufacturing of highly effective and expensive Drug Products, especially the ones listed in the Essential Drugs List.

Along with the Generic Drugs and Biosimilars, Rus BioPharm is also developing and launching novel Drug Products in the Russian market.
The lead therapeutic areas are as follows:
Antiretroviral therapy
Assisted Reproductive Technologies
Anesthesiology and Intensive Care Therapies
Orphan Diseases

Our Products
Biological Products and Biosimilars
One of the key focus area of Rus BioPharm is development of Biological and Biosimilar Drug Products for severe Rheumatology, Onco-Hematology, Gastroenterology and Reproductive disorders.
6 additional Biosimilars in different stages of development

Inhalation Drugs
Pulmonology is one of the key focus areas for Rus BioPharm and Rus BioPharm is developing a wide range of Inhalation Drugs Products for Asthma and Chronic Obstructive Pulmonary Disease, in all possible Drug Forms: Aerosols, Powders, Solutions and Suspensions for inhalation
Metered Dose Inhalers
And more than 4 innovative products at the development stage
Dry Powder Inhalers
And more than 5 innovative products at the development stage (R&D)
Solutions and Suspensions for Inhalation
More than 7 products are under development

Sterile Injectables
Rus BioPharm is developing a wide range of Drugs Products for Hospital segment, such as new generation Antibiotics, Antimycotics, Proton pump inhibitors and a number of other Drugs from the Essential Drugs List, in 3 Drug forms: lyophilizates, Solutions and Concentrates.
More than 13 products are under development

Solid Dosage Forms
Rus BioPharm's OSD Drug Product range covers diseases such as HIV, Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, etc.
More than 4 products are under development

Rus BioPharm's manufacturing facility is equipped with the latest and best available technology to effectively manufacture finished Drug Products with high added-value.

Robust Fill & Finish lines to cover all Drug Forms
Implementation of the latest GxP Practices
Highly productive manufacturing process with no compromise on Quality
Continuous professional development of highly skilled employees

Pharmaceutical Capabilities
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Metered Dose Solutions and suspensions for Inhalation
  • Lyophilised drugs for injection
  • Solutions and Concentrates for Injections
  • Solid Dosage Forms
  • Biological Drugs and Biosimilars – Injectable Solutions Sterile solution (Vial, PFS, Cartridge), Lyophilised form
  • Kilo Lab for API synthesis -
    Pilot small molecule API synthesis
  • Bioprocessing unit with USP and DSP -
    Biological Drug Substance ( Mammalian, Microbial)

Quality control
All Products are manufactured at a modern facility
The plant is equipped with all the necessary manufacturing and analytical equipment, to carry out most vigorous Quality Control assays.
Rus BioPharm uses New Generation Impactors to analyze Inhalation Drug forms, to determine the exact amount of API that reaches the deep parts of lungs during inhalation. This is a key characteristic to determine the quality of these Drug formulations. Rus BioPharm also uses Sympatec to analyze the distribution of particle sizes, to efficiently analyze the quality of the API used
Microbiological and Analytical laboratories have the necessary equipment for the analysis of Biological Products with latest technology and methods.
The President of Rus Biopharm Satya Karm Punia spoke to Russia Today about the opportunities for Indian companies in the Russian market
Happy New Year
PSK Pharma wishes colleagues and partners a Merry Christmas and a Happy New Year
World COPD Day
The date is celebrated annually on the third Wednesday of November.
Professor of the Sechenov First Moscow State Medical University Elena Popova discussed which modern drugs to choose from the PSK Pharma portfolio, what modern approaches to apply to the treatment of COPD. Look the video in our telegram channel ↪

Futureу CAR-T in Russia
PSK Pharma supported the scientific and practical conference «CAR-T Academy. Day 0 of CAR-T therapy in Russia».
The President of Rus Biopharm Satya Punia participated at the Conference, where met with the key opinion leaders in the field of hematology oncology
    Fully integrated bio-pharmaceutical company PSK Pharma (part of Rus Biopharm Group) takes part in the Russia—India Business Forum: Strategic Partnership for Development and Growth. The Forum started today in New Delhi.
    The business programme architecture of the Healthy Life Forum, which will take place at Tauride Palace in St. Petersburg on 23–24 March 2023, has been released on the official website of the Roscongress Foundation's Healthy Life project
    Biological synthesis is the most complex process in the pharmaceutical industry, and PSK Pharma is one of the few companies in Russia that successfully develops this area
    The supplier of the first generic sodium colistimethate in Russia can become a resident of the SEZ Dubna - the company " PSK Pharma»
    Satya Karm Punia, President of Rus BioPharm Group, attended Moscow Region roadshow in New Delhi and shared his experience with fellow Indian investors
    Biopharmaceutical company PSK Pharma is doubling its investment in the project in Moscow region. We are focused on Asthma and COPD drugs, Innovative and technology driven formulations
    The Governor of the Moscow Region, Andrei Vorobyev's interview to TV channel 3600 about the inauguration of Rus BioPharm's Pharmaceutical Manufacturing plant in Special Economic Zone Dubna.
    PSK Pharma, a resident of the Special Economic Zone Dubna, built a plant to manufacture Innovative Drugs.
    Russian Presidential Envoy and the Governor of Moscow Region inaugurated a bridge across Volga and new Manufacturing lines of SEZ Dubna Resident
    Innovative pharmaceutical facility will be established in Dubna city, Moscow region. Investments will amount to about 2.3 billion rubles..

    Our multinational team brings together professionals in various areas of the pharmaceutical industry. Along with good growth opportunities, we provide world class working atmosphere to our team members
    If you want to be a part of Rus BioPharm team, we are waiting for your resumes at
      15, 1st Krasnogvardeysky lane,
      39th floor, Mercury Tower,
      Moscow International Business Center,
      123112, Russian Federation,
      Phone: +7 499 400 16 99
      Manufacturing Facility
      5, Programmistov Street, bld.1
      Special Economic Zone "Dubna"
      Dubna, Moscow Region
      Russian Federation, 141983
      Phone: +7 496 218 19 19
      Pharmacovigilance hotline
      Phone: 8 (800) 234-16-99
      (free 24 h)